Boston Scientific acquires company for USD 1.75bn

Ambu competitor Boston Scientific has acquired Baylis Medical Company.

Photo: AP Photo/Marcio Jose Sanchez

Medtech company Boston Scientific, which is one of Ambu's competitors on the market for single-use scopes, has acquired Baylis Medical Company for USD 1.75bn, Bloomberg News reports.

Boston Scientific states that the companies have entered into a binding agreement, and the deal is expected to be finalized during the first quarter of 2022.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs